MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry
ConditionAortic Valve Stenosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorProf. Dr. med. Ingo Eitel
About this trial
Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.
Eligibility criteria
Qualifiers
Patient is going to be treated with Myval THV
Age ≥ 18 years
Ability to give informed consent
Disqualifiers
Pregnant and lactating women
Patients with hyper sensitivity or allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast media.
Patients in whom anti-platelet and/or anticoagulant therapy are contra-indicated.
Any condition, which in the Investigator's opinion, would preclude safe participation of patient in the registry
Trial design
Treatments tested in this trial
- Myval Transcatheter Heart Valve
Treatment groups
No treatment groups listed
Sponsors and collaborators
Prof. Dr. med. Ingo Eitel
Lead sponsor
University of Luebeck
Sponsor institution
Source ClinicalTrials.gov